Effects of Danggui Buxue Decoction on Endothelial Progenitor Cells,serum VEGF and SDF-1 in Atherosclerotic Rabbits

QIN Zhen,HUANG Shui-qing
DOI: https://doi.org/10.3969/j.issn.1000-4718.2012.02.004
2012-01-01
Abstract:AIM: To investigate the effects of Danggui Buxue decoction(DBD) on serum vascular endothelial growth factor(VEGF) and stromal cell-derived factor 1(SDF-1),as well as the activity of circulating endothelial progenitor cells(EPCs) in atherosclerotic rabbits.METHODS: The model of atherosclerosis was established using immune injury and fatty diet for 4 weeks in New Zealand rabbits(n=25).All modeled rabbits were randomized into 5 groups with 5 animals in each group.The rabbits in atherosclerosis group were intragastrically administered with distilled water.The rabbits in simvastatin group were treated with simvastatin at the dose of 1.7 mg/kg.The rabbits in DBD high-dose,middle-dose and low-dose treatment groups were given DBD at the doses of 6 g/kg,3 g/kg and 1.5 g/kg,respectively.All drugs were given once a day for 2 weeks.After treatment,the levels of serum VEGF and SDF-1 were measured.The mononuclear cells isolated from the rabbit peripheral blood were cultured for 7 days in vitro,and then attached cells were cultured with both DiI-ac-LDL and FITC-UEA-1 for identification.The proliferation was detected by MTT method.The cell migration was observed using Transwell chambers.The adhesion determination and in vitro angiogenesis assay were also performed.RESULTS: Compared with atherosclerosis group,the levels of serum VEGF and SDF-1 were elevated(P0.05),the proliferation,migration,adhesion and angiogenesis of EPCs were all improved in DBD high-dose,middle-dose treatment groups and simvastatin group(P0.05).CONCLUSION: DBD elevates the levels of serum VEGF and SDF-1 to improve the activity of EPCs in the process of atherosclerosis.
What problem does this paper attempt to address?